Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update – October 2015

Latest ICON clinical update

Dr David Eedes, Clinical Oncology Advisor at ICON, unpacks some of the key elements of ASCO’s updated guidelines on the use of of hematopoietic colony-stimulating factors (CSFs), a treatment option for neutropenia.

Read more Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update – October 2015